CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
21.44
-0.62 (-2.81%)
Jan 17, 2025, 4:00 PM EST - Market closed
CareDx Revenue
CareDx had revenue of $82.88M in the quarter ending September 30, 2024, with 23.35% growth. This brings the company's revenue in the last twelve months to $312.78M, up 5.26% year-over-year. In the year 2023, CareDx had annual revenue of $280.32M, down -12.89%.
Revenue (ttm)
$312.78M
Revenue Growth
+5.26%
P/S Ratio
3.60
Revenue / Employee
$486,431
Employees
643
Market Cap
1.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
Dec 31, 2019 | 127.07M | 50.50M | 65.95% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
CDNA News
- 7 days ago - CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results - Business Wire
- 27 days ago - CareDx: Top Of My Shopping List For 2025 - Seeking Alpha
- 4 weeks ago - CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 5 weeks ago - TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - PRNewsWire
- 5 weeks ago - CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - Business Wire
- 2 months ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - CareDx, Inc (CDNA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance - Business Wire